Targeted therapy, aiming, for instance, at antitumor treatments, can be divided into active and passive forms [ 72, 73 ]. Passive targeting is based on higher vascularity and higher vascular permeability of the tumor, as well as inflamed tissues, compared to physiological ones [ 73, 74 ]. Additionally, the lymphatic circulation of the tumor shows decreased efficiency [ 25 ], which led to easier accumulation of nanoparticles in the tumor or inflamed tissues [ 10, 27, 72, 74 ]. This passive accumulation is normally called "ELVIS" (Extravasation through Leaky Vasculature and later Inflammatory cell-mediated Sequestration) [ 72, 74 ]. From the facet of surface qualities, negatively charged nanoparticles accumulate less effectively inside cells, due to the negatively charged cell membrane, which slows down the cellular uptake, so, in this case, a neutral surface charge is more favorable [ 25 ]. In contrast, active targeting can be accomplished by functionalizing the outer surface of the silica carriers [ 10, 27, 72 ], where molecules are attached to the surface of the carriers that specifically bind to certain cell surface ligands and receptors, which are characteristic of tumor-, but not of healthy cells. This selective method provides more effective treatment and reduces the side impacts of cytotoxic APIs on healthy cells and tissues [ 10, 27 ]. The most recent findings on active targeting possibilities are summarized in Table 3. García-Fernández et al. prepared a mesoporous silica-based nanocarrier loaded with dexamethasone and capped with a particular protein to actively target the TNFR1 receptor, which is overexpressed in pro-inflammatory macrophages [ 72 ]. Since the carriers are preferably internalized by these macrophages, the cargo is released in a controlled manner, during enzymatic hydrolysis, thus preventing premature drug release, thanks to the gatekeepers. The targeting talent was tested in vitro with activated macrophages. On the other hand, the therapeutic efficiency was tested in vivo in mouse models. The researchers observed greater therapeutic impacts and fewer adverse side influences than in the case of free dexamethasone. To sum up, dexamethasone-loaded MSN has been effectively developed to actively target the lungs in acute lung injury (ALI), and this result may also be promising in other lung diseases (COPD, asthma) [ 72 ]. Teruel et al. presented a novel approach in oral inflammatory bowel sickness (IBD) therapy, using functionalized magnetic mesoporous silica microparticles [ 75 ].
Matting Agent for Coatings: Types, Selection Guide and Performance Comparison
Silica for Rheology Control: How to Select the Right Silica and Dosage
Silica as a Polishing Agent: How It Works and Where It Is Used
Electronic Grade Silica: Purity Requirements, Specifications and Applications
47. Aulifa D.L., Saepudin A.H., Margaretha P., Khairinisa M.A., Budiman A. Characterization of Alpha Mangostin Loaded-Mesoporous Silica Nanoparticle and the Impact on Dissolution and Physical Stability. Nanotechnol. Sci. Appl. 2025;18:1-13. doi: 10.2147/NSA.S499007. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
Silica Carrier for Pesticides: Absorption Capacity, Flowability and Grade Selection
53. Kramarczyk D., Knapik-Kowalczuk J., Smolka W., Monteiro M.F., Tajber L., Paluch M. Inhibition of celecoxib crystallization by mesoporous silica - Molecular dynamics studies leading to the discovery of the stabilization origin. Eur. J. Pharm. Sci. 2022;171:106132. doi: 10.1016/j.ejps.2022.106132. [ DOI ] [ PubMed ] [ Google Scholar ]
What Is Silica Powder? Types, Particle Sizes, Grades and Common Applications
What is silica (SiO₂)?
Denka spherical silica
What is the difference between fumed silica and precipitated silica?
custom silica
60. Fu Y., Kao W.J. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert. Opin. Drug Deliv. 2010;7:429-444. doi: 10.1517/17425241003602259. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
What drives silica raw material prices?
silica supplier UAE
This supports that the release rate depends on several components, among others, influenced by the pore size, the pore structure, the amount of drug loaded, the solubility of the API, and the resulting interaction between the carrier and the transported molecules [ 2 ]. By modifying these, the release kinetics can be controlled to a small extent, but a considerable influence can only be attained by surface functionalization of the mesopores. The following table contains some experimental data in terms of drug release in case of the previously shown APIs ( Table 2 ).
Cite this article: Silica Raw Materials News. "Silica for Printing Ink: Functions, Grades and Formulation Tips
." Published 2026-11-20 00:56:24. /news/article.html Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.